A Disease Hidden in Plain Sight: Pathways and Mechanisms of Neurological Complications of Post-acute Sequelae of COVID-19 (NC-PASC)

被引:0
|
作者
Saxena, Apoorva [1 ]
Mautner, Josef [2 ]
机构
[1] Ludwig Maximilians Univ Munchen, Dept Biol, Munich, Germany
[2] Helmholtz Zent Munchen, Inst Virol, Munich, Germany
关键词
COVID-19; SARS-CoV-2; Long COVID; NC-PASC; Neurological symptoms; Pathophysiological mechanisms; SARS-COV-2; NEUROPATHOLOGY; VARIANTS;
D O I
10.1007/s12035-024-04421-z
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The global impact of coronavirus disease 2019 (COVID-19) marked by numerous pandemic peaks is attributed to its high variability and infectious nature, transforming it into a persistent global public health concern. With hundreds of millions of cases reported globally, the illness is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite its initial classification as an acute respiratory illness, recent evidence indicates that lingering effects on various bodily systems, such as cardiovascular, pulmonary, nervous, gastrointestinal (GI), and musculoskeletal, may endure well beyond the acute phase. These persistent manifestations following COVID-19, commonly known as long COVID, have the potential to affect individuals across the entire range of illness severity, with a tendency to be more prevalent in mild to moderate cases. At present, there are no established criteria for diagnosing long COVID. Nonetheless, it is conceptualized as a multi-organ disorder encompassing a diverse array of clinical manifestations. The most common, persistent, and debilitating symptoms of long COVID may be neurological, known as neurological complications of post-acute sequelae of COVID-19 (NC-PASC). More than one-third of individuals with a prior SARS-CoV-2 infection show involvement of both the central nervous system (CNS) and peripheral nervous system (PNS), as evidenced by an approximately threefold higher incidence of neurological symptoms in observational studies. The persistent neurological symptoms of long COVID encompass fatigue, headache, cognitive decline, "brain fog", dysautonomia, neuropsychiatric issues, loss of smell (anosmia), loss of taste (ageusia), and peripheral nerve problems (peripheral neuropathy). Reported pathogenic mechanisms encompass viral persistence and neuro-invasion by SARS-CoV-2, neuroinflammation, autoimmunity, coagulopathy, and endotheliopathy. Raising awareness of potential complications is crucial for preventing and alleviating the long-term effects of long COVID and enhancing the prognosis for affected patients. This review explores the hypothetical pathophysiological mechanisms and pathways of NC-PASC with a sole aim to increase awareness about this crippling disease.
引用
收藏
页码:2530 / 2547
页数:18
相关论文
共 50 条
  • [21] Objective cardiovascular autonomic abnormalities persist over time in patients with Post-Acute Sequelae of COVID-19 (PASC)
    Hira, Rashmin
    Siddiqui, Tanya
    Baker, Jacquie
    Bourne, Kate
    Ranada, Shaun
    Soroush, Ateyeh
    Karalasingham, Kavithra
    Ahmad, Hyeqa
    Morillo, Carlos
    Sheldon, Robert
    Raj, Satish
    PHYSIOLOGY, 2023, 38
  • [22] Repurposing exercise training and pharmacological therapies to address the post-acute sequelae of COVID-19 (PASC) in diabetes mellitus
    Chee, Ying Jie
    Dalan, Rinkoo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 199
  • [23] Post-acute sequelae of COVID-19 in solid organ transplant recipients
    Sigler, Rachel
    Covarrubias, Karina
    Chen, Benjamin
    Rubarth, Rodrigo Barriola
    Torosian, Kelly
    Sanchez, Claudia Ramirez
    Bharti, Ajay
    Degruttola, Victor
    Aslam, Saima
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (06)
  • [24] Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection part 2: Psychological functioning
    Whiteside, Douglas M.
    Naini, Savana M.
    Basso, Michael R.
    Waldron, Eric J.
    Holker, Erin
    Porter, James
    Niskanen, Natalie
    Melnik, Tanya E.
    Taylor, Sarah E.
    CLINICAL NEUROPSYCHOLOGIST, 2022, 36 (04) : 829 - 847
  • [25] Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection Part 1: Cognitive functioning
    Whiteside, Douglas M.
    Basso, Michael R.
    Naini, Savana M.
    Porter, James
    Holker, Erin
    Waldron, Eric J.
    Melnik, Tanya E.
    Niskanen, Natalie
    Taylor, Sarah E.
    CLINICAL NEUROPSYCHOLOGIST, 2022, 36 (04) : 806 - 828
  • [26] Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
    Etheresia Pretorius
    Mare Vlok
    Chantelle Venter
    Johannes A. Bezuidenhout
    Gert Jacobus Laubscher
    Janami Steenkamp
    Douglas B. Kell
    Cardiovascular Diabetology, 20
  • [27] Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19
    Soares, Madu N.
    Eggelbusch, Moritz
    Naddaf, Elie
    Gerrits, Karin H. L.
    van der Schaaf, Marike
    van den Borst, Bram
    Wiersinga, W. Joost
    van Vugt, Michele
    Weijs, Peter J. M.
    Murray, Andrew J.
    Wust, Rob C. I.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2022, 13 (01) : 11 - 22
  • [28] Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). Updated Terminology for the Long-Term Effects of COVID-19
    Parums, Dinah, V
    MEDICAL SCIENCE MONITOR, 2023, 29
  • [29] Signatures of Mitochondrial Dysfunction and Impaired Fatty Acid Metabolism in Plasma of Patients with Post-Acute Sequelae of COVID-19 (PASC)
    Guntur, Vamsi P.
    Nemkov, Travis
    de Boer, Esther
    Mohning, Michael P.
    Baraghoshi, David
    Cendali, Francesca, I
    San-Millan, Inigo
    Petrache, Irina
    D'Alessandro, Angelo
    METABOLITES, 2022, 12 (11)
  • [30] Microbiome and intestinal pathophysiology in post-acute sequelae of COVID-19
    Zhang, Jilei
    Zhang, Yongguo
    Xia, Yinglin
    Sun, Jun
    GENES & DISEASES, 2024, 11 (03)